エネルギー代謝におけるＧタンパク質共役型受容体（GPCR）シグナルの重要性

1）　Wang L, Pydi SP, Zhu L, et al : Adipocyte Gi signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity. Nat Commun 11 : 2995, 2020

2）　Tanaka N, Kimura T, Fujimori N, et al : Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol 25 : 163-177, 2019

3）　Kimura T, Namkoong H : Susceptibility of the obese population to COVID-19. Int J Infect Dis 101 : 380-381, 2020

4）　Roden M, Shulman GI : The integrative biology of type 2 diabetes. Nature 576 : 51-60, 2019

5）　Kimura T, Pydi SP, Pham J, et al : Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD. Biomolecules 10, 2020

6）　Pydi SP, Jain S, Barella LF, et al : beta-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia. Sci Adv 6 : eaba1733, 2020

7）　Barella LF, Jain S, Kimura T, et al : Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. FEBS J 288 : 2622-2644, 2021

8）　Wang L, Zhu L, Meister J, et al : Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs. Annu Rev Pharmacol Toxicol 61 : 421-440, 2021

9）　Reimann F, Gribble FM : G protein-coupled receptors as new therapeutic targets for type 2 diabetes. Diabetologia 59 : 229-233, 2016

10）　Lamont BJ, Li Y, Kwan E, et al : Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J Clin Invest 122 : 388-402, 2012

11）　Ackeifi C, Wang P, Karakose E, et al : GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration. Sci Transl Med 12, 2020

12）　Barella LF, Rossi M, Pydi SP, et al : beta-Arrestin-1 is required for adaptive beta-cell mass expansion during obesity. Nat Commun 12 : 3385, 2021

13）　Zhu L, Dattaroy D, Pham J, et al : Intra-islet glucagon signaling is critical for maintaining glucose homeostasis. JCI Insight 5, 2019

14）　Exton JH : Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu Rev Pharmacol Toxicol 36 : 481-509, 1996

15）　Ueno H, Ito R, Abe SI, et al : SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity. J Pharmacol Exp Ther 370 : 172-181, 2019

16）　Kaku K, Enya K, Nakaya R, et al : Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes : a 52-week open-label phase III study. Diabetes Obes Metab 18 : 925-929, 2016

17）　Oh DY, Walenta E, Akiyama TE, et al : A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med 20 : 942-947, 2014

18）　Stone VM, Dhayal S, Brocklehurst KJ, et al : GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia 57 : 1182-1191, 2014

19）　Kimura T, Singh S, Tanaka N, et al : Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 12 : 773432, 2021

20）　Ozcan L, Wong CC, Li G, et al : Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 15 : 739-751, 2012

21）　Boland ML, Laker RC, Mather K, et al : Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis. Nat Metab 2 : 413-431, 2020

22）　Khan SA, Sathyanarayan A, Mashek MT, et al : ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1alpha/ PPAR-alpha signaling. Diabetes 64 : 418-426, 2015

23）　Rossi M, Zhu L, McMillin SM, et al : Hepatic Gi signaling regulates whole-body glucose homeostasis. J Clin Invest 128 : 746-759, 2018

24）　Gonzalez-Benitez E, Guinzberg R, Diaz-Cruz A, et al : Regulation of glycogen metabolism in hepatocytes through adenosine receptors. Role of Ca2＋ and cAMP. Eur J Pharmacol 437 : 105-111, 2002

25）　Jacobson KA, Tosh DK, Jain S, et al : Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development. Front Cell Neurosci 13 : 124, 2019

26）　Li JH, Jain S, McMillin SM, et al : A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes in vivo. Endocrinology 154 : 3539-3551, 2013

27）　Ding C, Leow MK, Magkos F : Oxytocin in metabolic homeostasis : implications for obesity and diabetes management. Obes Rev 20 : 22-40, 2019

28）　Kang S, Huang J, Lee BK, et al : Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120). Biochim Biophys Acta Mol Cell Biol Lipids 1863 : 105-116, 2018

29）　On S, Kim HY, Kim HS, et al : Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosa hexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes. Int J Mol Sci 20, 2019

30）　DeFronzo RA, Gunnarsson R, Bjorkman O, et al : Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76 : 149-155, 1985

31）　Merlin J, Evans BA, Csikasz RI, et al : The M3-muscarinic acetylcholine receptor stimulates glucose uptake in L6 skeletal muscle cells by a CaMKK-AMPK-dependent mechanism. Cell Signal 22 : 1104-1113, 2010

32）　Bone DBJ, Meister J, Knudsen JR, et al : Skeletal Muscle-Specific Activation of Gq Signaling Maintains Glucose Homeostasis. Diabetes 68 : 1341-1352, 2019

33）　Jain S, Pydi SP, Toti KS, et al : Lack of adipocyte purinergic P2Y6 receptor greatly improves whole body glucose homeostasis. Proc Natl Acad Sci U S A 117 : 30763-30774, 2020

34）　Sato M, Dehvari N, Oberg AI, et al : Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes 63 : 4115-4129, 2014

35）　Gnad T, Navarro G, Lahesmaa M, et al : Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity. Cell Metab 32 : 56-70 e57, 2020

36）　Simoneau JA, Kelley DE : Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol (1985) 83 : 166-171, 1997

37）　Koo JH, Kim TH, Park SY, et al : Galpha13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism. J Clin Invest 127 : 3845-3860, 2017

38）　Pydi SP, Jain S, Tung W, et al : Adipocyte beta-arrestin-2 is essential for maintaining whole body glucose and energy homeostasis. Nat Commun 10 : 2936, 2019

39）　Cypess AM, Weiner LS, Roberts-Toler C, et al : Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist. Cell Metab 21 : 33-38, 2015

40）　O’Mara AE, Johnson JW, Linderman JD, et al : Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest 130 : 2209-2219, 2020

41）　Finlin BS, Memetimin H, Zhu B, et al : The beta3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J Clin Invest 130 : 2319-2331, 2020

42）　Lockie SH, Heppner KM, Chaudhary N, et al : Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes 61 : 2753-2762, 2012

43）　Johansson SM, Lindgren E, Yang JN, et al : Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin. Eur J Pharmacol 597 : 92-101, 2008

44）　Pfeifer A, Hoffmann LS : Brown, beige, and white : the new color code of fat and its pharmacological implications. Annu Rev Pharmacol Toxicol 55 : 207-227, 2015

45）　Silvestri C, Di Marzo V : The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 17 : 475-490, 2013

46）　Kimura T, Pydi SP, Wang L, et al : Adipocyte Gq signaling is a regulator of glucose and lipid homeostasis in mice. Nat Commun 13 : 1652, 2022

47）　Kang NY, Soetedjo AAP, Amirruddin NS, et al : Tools for Bioimaging Pancreatic beta Cells in Diabetes. Trends Mol Med 25 : 708-722, 2019